Viewing Study NCT03392428


Ignite Creation Date: 2025-12-26 @ 11:13 AM
Ignite Modification Date: 2026-03-07 @ 1:48 PM
Study NCT ID: NCT03392428
Status: COMPLETED
Last Update Posted: 2022-06-13
First Post: 2017-12-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Trial of 177Lu-PSMA617 Theranostic Versus Cabazitaxel in Progressive Metastatic Castration Resistant Prostate Cancer
Sponsor: Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cancer of the Prostate View
None Metastatic Cancer View
Keywords: